Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001883126-22-000001
Filing Date
2022-04-04
Accepted
2022-04-04 16:26:12
Documents
1
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3311
  Complete submission text file 0001883126-22-000001.txt   5014
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIVIUM WESTLAAN 142 CAPELLE AAN DEN LJSSEL P7 2909LD
Business Address RIVIUM WESTLAAN 142 CAPELLE AAN DEN LJSSEL P7 2909LD 31-104064349
PF Equity Holdings 1 B.V. (Reporting) CIK: 0001883126 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 22802607